HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determinants of heterotopic ossification after total hip replacement surgery.

Abstract
The ability of various pre- or peri-operative variables to determine the risk of developing moderate to severe heterotopic ossification (HO) six to twelve months after surgery was investigated among 407 patients undergoing elective total hip replacement (THR) surgery and allocated to placebo in a randomised controlled trial evaluating NSA IDs-based prophylaxis for HO. Overall, 11 (30%) of the 37 patients undergoing revision surgery developed moderate to severe HO compared with 58 (16%) of the 370 patients undergoing primary THR; odds ratio (OR) 2.3, 95% confidence interval (CI) 1.1 to 4.9. Among patients undergoing primary THR , mutually adjusted analysis of collected independent risk factors demonstrated that receiving a transfusion of red cells or having general as well as epidural or spinal anaesthesia present as indicators of increased risk for developing moderate to severe HO. Patients who have undergone revision surgery have a significantly increased risk of clinically relevant ectopic bone, while among patients who have undergone primary THR surgery, those with indicators of excessive surgical bleeding are also at increased risk of clinically relevant HO.
AuthorsMarlene Fransen, Bruce Neal, Ian D Cameron, Ross Crawford, Garnet Tregonning, Julie Winstanley, Robyn Norton, HIPAID Collaborative Group
JournalHip international : the journal of clinical and experimental research on hip pathology and therapy (Hip Int) 2009 Jan-Mar Vol. 19 Issue 1 Pg. 41-6 ISSN: 1724-6067 [Electronic] United States
PMID19455501 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Placebos
Topics
  • Aged
  • Anesthesia, Epidural (adverse effects)
  • Anesthesia, Spinal (adverse effects)
  • Arthroplasty, Replacement, Hip (adverse effects)
  • Blood Loss, Surgical
  • Erythrocyte Transfusion (adverse effects)
  • Female
  • Humans
  • Male
  • Odds Ratio
  • Ossification, Heterotopic (etiology)
  • Placebos
  • Reoperation (adverse effects)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: